This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a piperidine ring and a benzo[d]isothiazole moiety, makes it a valuable intermediate in the creation of molecules targeting central nervous system (CNS) disorders. Researchers often explore its potential in designing compounds with activity against neurological conditions such as schizophrenia, anxiety, or depression. Additionally, its unique chemical framework allows for modifications that can enhance bioavailability or selectivity in drug design. The compound is also of interest in medicinal chemistry for its potential role in developing protease inhibitors or other enzyme-targeting therapeutics. Its applications extend to preclinical studies, where it is used to investigate pharmacological properties and optimize drug efficacy.